Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Axel Ullrich

Showing results (91-100 of 122) with videos related to

Pageof 13
Sort By:
International Journal of Cancer|July 15, 2006
Active antimetastatic immunotherapy in Lewis lung carcinoma with self EGFR extracellular domain protein in VSSP adjuvantBelinda Sánchez Ramírez, Eduardo Suárez Pestana, Greta Garrido Hidalgo, et al.
The EMBO Journal|January 21, 2006
EphB4 controls blood vascular morphogenesis during postnatal angiogenesisRalf Erber, Uta Eichelsbacher, Violetta Powajbo, et al.
International Journal of Cancer|April 19, 2012
Combinatorial treatment of mammospheres with trastuzumab and salinomycin efficiently targets HER2-positive cancer cells and cancer stem cellsPrajakta S Oak, Florian Kopp, Chitra Thakur, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 6, 2003
Combined inhibition of VEGF and PDGF signaling enforces tumor vessel regression by interfering with pericyte-mediated endothelial cell survival mechanismsRalf Erber, Andreas Thurnher, Alice D Katsen, et al.
Surgery|November 26, 2003
Pancreatic cancer growth is inhibited by blockade of VEGF-RIIPeter Büchler, Howard A Reber, Axel Ullrich, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 11, 2006
FGFR4 Arg388 allele is associated with resistance to adjuvant therapy in primary breast cancerChristoph Thussbas, Jorg Nahrig, Sylvia Streit, et al.
Nature Medicine|May 2, 2006
Mig6 is a negative regulator of EGF receptor-mediated skin morphogenesis and tumor formationIngvar Ferby, Markus Reschke, Oliver Kudlacek, et al.
Cancer Research|March 15, 2008
AXL is a potential target for therapeutic intervention in breast cancer progressionYi-Xiang Zhang, Peter G Knyazev, Yuri V Cheburkin, et al.
Molecular and Cellular Biology|May 15, 2004
Mitochondrial AKAP121 binds and targets protein tyrosine phosphatase D1, a novel positive regulator of src signalingLuca Cardone, Annalisa Carlucci, Adele Affaitati, et al.
The Journal of Cell Biology|April 26, 2006
Estrogen transactivates EGFR via the sphingosine 1-phosphate receptor Edg-3: the role of sphingosine kinase-1Olga Sukocheva, Carol Wadham, Andrew Holmes, et al.
Pageof 13

Showing results (91-100 of 122) with videos related to

Sort By:
Pageof 13
International Journal of Cancer|July 15, 2006
Active antimetastatic immunotherapy in Lewis lung carcinoma with self EGFR extracellular domain protein in VSSP adjuvantBelinda Sánchez Ramírez, Eduardo Suárez Pestana, Greta Garrido Hidalgo, et al.
The EMBO Journal|January 21, 2006
EphB4 controls blood vascular morphogenesis during postnatal angiogenesisRalf Erber, Uta Eichelsbacher, Violetta Powajbo, et al.
International Journal of Cancer|April 19, 2012
Combinatorial treatment of mammospheres with trastuzumab and salinomycin efficiently targets HER2-positive cancer cells and cancer stem cellsPrajakta S Oak, Florian Kopp, Chitra Thakur, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 6, 2003
Combined inhibition of VEGF and PDGF signaling enforces tumor vessel regression by interfering with pericyte-mediated endothelial cell survival mechanismsRalf Erber, Andreas Thurnher, Alice D Katsen, et al.
Surgery|November 26, 2003
Pancreatic cancer growth is inhibited by blockade of VEGF-RIIPeter Büchler, Howard A Reber, Axel Ullrich, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 11, 2006
FGFR4 Arg388 allele is associated with resistance to adjuvant therapy in primary breast cancerChristoph Thussbas, Jorg Nahrig, Sylvia Streit, et al.
Nature Medicine|May 2, 2006
Mig6 is a negative regulator of EGF receptor-mediated skin morphogenesis and tumor formationIngvar Ferby, Markus Reschke, Oliver Kudlacek, et al.
Cancer Research|March 15, 2008
AXL is a potential target for therapeutic intervention in breast cancer progressionYi-Xiang Zhang, Peter G Knyazev, Yuri V Cheburkin, et al.
Molecular and Cellular Biology|May 15, 2004
Mitochondrial AKAP121 binds and targets protein tyrosine phosphatase D1, a novel positive regulator of src signalingLuca Cardone, Annalisa Carlucci, Adele Affaitati, et al.
The Journal of Cell Biology|April 26, 2006
Estrogen transactivates EGFR via the sphingosine 1-phosphate receptor Edg-3: the role of sphingosine kinase-1Olga Sukocheva, Carol Wadham, Andrew Holmes, et al.
Pageof 13